Global Contract Research Organization Services (CROs) Market – Global Industry Analysis and Forecast (2017-2024) _ by Type, by Therapeutic Area, by End-User, and by Geography

Global Contract Research Organization Services (CROs) Market – Global Industry Analysis and Forecast (2017-2024) _ by Type, by Therapeutic Area, by End-User, and by Geography

Market Scenario

Global Contract Research Organization Services (CROs) Market is expected to reach USD 60.9 Billion by 2024 from USD 33.8 Billion in 2016 at CAGR of 7.64% (Detailed analysis of the market CAGR is provided in the report). Global Contract Research Organization Service (CROs) Market Various factors driving the Contract Research Organization Services (CROs) market growth are increasing the prevalence of diseases such as cardiovascular, diabetes, & oncological, a robust pipeline of pharmaceutical & biopharmaceutical products, and increasing complexity of clinical trials and fast-paced changing regulatory framework associated with commercialization. Global Contract Research Organization Services (CROs) Market is segmented by type, therapeutic area, end user, and geography. Type segment is sub-segmented as early phase development service, clinical research services, laboratory services and consulting services. Therapeutic Area segment is classified as oncology, infectious diseases, central nervous system (CNS) disorders, immunological disorders, and others. End-user segment is divided as pharmaceutical & biopharmaceutical companies, medical device companies, and academic institutes. Pharmaceutical & biopharmaceutical companies end-user segment is expected to register highest growth rate during the forecast period, owing to increased outsourcing of early phase development services and clinical and laboratory testing services by pharmaceutical companies to increase profit margins. The market on the basis of geography is segmented by North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Increased outsourcing of R&D activities and the increasing number of clinical trials are trending the overall Global Contract Research Organization Services (CROs) Market. However, shortage of skilled professionals will restrain the market growth. North America is expected to dominate the Contract Research Organization Services (CROs) Market in forecast period followed by Europe and APAC. Technologically advanced research, the increase in clinical trial activity and high-quality standards in the pharmaceutical industry in this region will fuel the Contract Research Organization Services (CROs) Market in the North America region. Key Highlights: • Assessment of market definition along with the identification of key players and analysis of their strategies to determine the competitive outlook of the market, opportunities, drivers, restraints and challenges for this market during the forecast period • Complete quantitative analysis of the industry from 2016 to 2024 to enable the stakeholders to capitalize on the prevailing market opportunities • In-depth analysis of the industry on the basis of market segments, market dynamics, market size, competition & companies involved value chain • Global Contract Research Organization Services (CROs) Market analysis and comprehensive segmentation with respect to the type, therapeutic area, end user, and geography to assist in strategic business planning • Global Contract Research Organization Services (CROs) Market analysis and forecast for five major geographies North America, Europe, Asia Pacific, Middle East & Africa, Latin America and their key regions

Scope of the Global Contract Research Organization Services (CROS) Market

Global Contract Research Organization Services (CROS) Market, By Type:

• Early Phase Development Services o Discovery Studies o Chemistry, Manufacturing & Control o Preclinical Services • Pharmacokinetics/Pharmacodynamics (PK/PD) • Toxicology Testing • Others • Clinic Research Services o Phase I o Phase II o Phase III o Phase IV • Laboratory Services o Bioanalytical Testing o Analytical Testing • Physical Characterization • Stability Testing • Batch Release Testing • Raw Material Testing • Other Analytical Testing • Consulting Services

Global Contract Research Organization Services (CROS) Market, By Therapeutic Area:

• Oncology • Infectious Diseases • Central Nervous System (CNS) Disorders • Immunological Disorders • Cardiovascular Diseases • Respiratory Disorders • Diabetes • Other Therapeutic Areas

Global Contract Research Organization Services (CROS) Market, By End-User:

• Pharmaceutical & Biopharmaceutical Companies • Medical Device Companies • Academic Institutes

Global Contract Research Organization Services (CROs) Market, By Geography:

• North America • Europe • Asia Pacific • Middle East & Africa • Latin America

Key Players in the Global Contract Research Organization Services (CROs) Market Are:

• MPI Research • Quintiles Transnational Holdings Inc. • Envigo • SGS • MeDPAce Holdings • Charles River • WuXi Pharmatech • INC Research Holdings, Inc. • Syneos Health • ICON PLC • PPD • PRA Health Sciences • PAREXEL • LabCorp • IQVIA Global Clinical Trial Imaging Market: Global Industry Analysis and Forecast 2024

Table of Contents

Global Contract Research Organization Services (CROs) Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Contract Research Organization Services (CROs) Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Contract Research Organization Services (CROs) Market Analysis and Forecast 6.1. Global Contract Research Organization Services (CROs) Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Contract Research Organization Services (CROs) Market Analysis and Forecast, by Therapeutic Area 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Contract Research Organization Services (CROs) Market Value Share Analysis, by Therapeutic Area 7.4. Global Contract Research Organization Services (CROs) Market Size (US$ Bn) Forecast, by Therapeutic Area 7.5. Global Contract Research Organization Services (CROs) Market Analysis, by Therapeutic Area 7.6. Global Contract Research Organization Services (CROs) Market Attractiveness Analysis, by Therapeutic Area 8. Global Contract Research Organization Services (CROs) Market Analysis and Forecast, by End-user 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Contract Research Organization Services (CROs) Market Value Share Analysis, by End-user 8.4. Global Contract Research Organization Services (CROs) Market Size (US$ Bn) Forecast, by End-user 8.5. Global Contract Research Organization Services (CROs) Market Analysis, by End-user 8.6. Global Contract Research Organization Services (CROs) Market Attractiveness Analysis, by End-user 9. Global Contract Research Organization Services (CROs) Market Analysis and Forecast, by Type 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Contract Research Organization Services (CROs) Market Value Share Analysis, by Type 9.4. Global Contract Research Organization Services (CROs) Market Size (US$ Bn) Forecast, by Type 9.5. Global Contract Research Organization Services (CROs) Market Analysis, by Type 9.6. Global Contract Research Organization Services (CROs) Market Attractiveness Analysis, by Type 10. Global Contract Research Organization Services (CROs) Market Analysis, by Region 10.1. Global Contract Research Organization Services (CROs) Market Value Share Analysis, by Region 10.2. Global Contract Research Organization Services (CROs) Market Size (US$ Bn) Forecast, by Region 10.3. Global Contract Research Organization Services (CROs) Market Attractiveness Analysis, by Region 11. North America Contract Research Organization Services (CROs) Market Analysis 11.1. Key Findings 11.2. North America Contract Research Organization Services (CROs) Market Overview 11.3. North America Contract Research Organization Services (CROs) Market Value Share Analysis, by Therapeutic Area 11.4. North America Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 11.4.1. Oncology 11.4.2. Infectious Diseases 11.4.3. Central Nervous System (CNS) Disorders 11.4.4. Immunological Disorders 11.4.5. Cardiovascular Diseases 11.4.6. Respiratory Disorders 11.4.7. Diabetes 11.4.8. Other Therapeutic Areas 11.5. North America Contract Research Organization Services (CROs) Market Value Share Analysis, by End-user 11.6. North America Contract Research Organization Services (CROs) Market Forecast, by End-user 11.6.1. Pharmaceutical & Biopharmaceutical Companies 11.6.2. Medical Device Companies 11.6.3. Academic Institutes 11.7. North America Contract Research Organization Services (CROs) Market Value Share Analysis, by Type 11.8. North America Contract Research Organization Services (CROs) Market Forecast, by Type 11.8.1. Early Phase Development Services 11.8.1.1. Discovery Studies 11.8.1.2. Chemistry, Manufacturing & Control 11.8.1.3. Preclinical Services 11.8.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 11.8.3. Toxicology Testing 11.8.4. Clinic Research Services 11.8.4.1. Phase I 11.8.4.2. Phase II 11.8.4.3. Phase III 11.8.4.4. Phase IV 11.8.5. Laboratory Services 11.8.5.1. Bioanalytical Testing 11.8.5.2. Analytical Testing 11.8.6. Physical Characterization 11.8.7. Stability Testing 11.8.8. Batch Release Testing 11.8.9. Raw Material Testing 11.8.10. Other Analytical Testing 11.8.11. Consulting Services 11.8.12. Other 11.9. North America Contract Research Organization Services (CROs) Market Value Share Analysis, by Country 11.10. North America Contract Research Organization Services (CROs) Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Contract Research Organization Services (CROs) Market Analysis, by Country 11.12. U.S. Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 11.12.1. Oncology 11.12.2. Infectious Diseases 11.12.3. Central Nervous System (CNS) Disorders 11.12.4. Immunological Disorders 11.12.5. Cardiovascular Diseases 11.12.6. Respiratory Disorders 11.12.7. Diabetes 11.12.8. Other 11.13. U.S. Contract Research Organization Services (CROs) Market Forecast, by End-user 11.13.1. Pharmaceutical & Biopharmaceutical Companies 11.13.2. Medical Device Companies 11.13.3. Academic Institutes 11.14. U.S. Contract Research Organization Services (CROs) Market Forecast, by Type 11.14.1. Early Phase Development Services 11.14.1.1. Discovery Studies 11.14.1.2. Chemistry, Manufacturing & Control 11.14.1.3. Preclinical Services 11.14.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 11.14.3. Toxicology Testing 11.14.4. Clinic Research Services 11.14.4.1. Phase I 11.14.4.2. Phase II 11.14.4.3. Phase III 11.14.4.4. Phase IV 11.14.5. Laboratory Services 11.14.5.1. Bioanalytical Testing 11.14.5.2. Analytical Testing 11.14.6. Physical Characterization 11.14.7. Stability Testing 11.14.8. Batch Release Testing 11.14.9. Raw Material Testing 11.14.10. Other Analytical Testing 11.14.11. Consulting Services 11.14.12. Other 11.15. Canada Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 11.15.1. Oncology 11.15.2. Infectious Diseases 11.15.3. Central Nervous System (CNS) Disorders 11.15.4. Immunological Disorders 11.15.5. Cardiovascular Diseases 11.15.6. Respiratory Disorders 11.15.7. Diabetes 11.15.8. Other 11.16. Canada Contract Research Organization Services (CROs) Market Forecast, by End-user 11.16.1. Pharmaceutical & Biopharmaceutical Companies 11.16.2. Medical Device Companies 11.16.3. Academic Institutes 11.17. Canada Contract Research Organization Services (CROs) Market Forecast, by Type 11.17.1. Early Phase Development Services 11.17.1.1. Discovery Studies 11.17.1.2. Chemistry, Manufacturing & Control 11.17.1.3. Preclinical Services 11.17.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 11.17.3. Toxicology Testing 11.17.4. Clinic Research Services 11.17.4.1. Phase I 11.17.4.2. Phase II 11.17.4.3. Phase III 11.17.4.4. Phase IV 11.17.5. Laboratory Services 11.17.5.1. Bioanalytical Testing 11.17.5.2. Analytical Testing 11.17.6. Physical Characterization 11.17.7. Stability Testing 11.17.8. Batch Release Testing 11.17.9. Raw Material Testing 11.17.10. Other Analytical Testing 11.17.11. Consulting Services 11.17.12. Other 11.18. North America Contract Research Organization Services (CROs) Market Attractiveness Analysis 11.18.1. By Therapeutic Area 11.18.2. By End-user 11.18.3. By Type 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Contract Research Organization Services (CROs) Market Analysis 12.1. Key Findings 12.2. Europe Contract Research Organization Services (CROs) Market Overview 12.3. Europe Contract Research Organization Services (CROs) Market Value Share Analysis, by Therapeutic Area 12.4. Europe Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 12.4.1. Oncology 12.4.2. Infectious Diseases 12.4.3. Central Nervous System (CNS) Disorders 12.4.4. Immunological Disorders 12.4.5. Cardiovascular Diseases 12.4.6. Respiratory Disorders 12.4.7. Diabetes 12.4.8. Other 12.5. Europe Contract Research Organization Services (CROs) Market Value Share Analysis, by End-user 12.6. Europe Contract Research Organization Services (CROs) Market Forecast, by End-user 12.6.1. Pharmaceutical & Biopharmaceutical Companies 12.6.2. Medical Device Companies 12.6.3. Academic Institutes 12.7. Europe Contract Research Organization Services (CROs) Market Value Share Analysis, by Type 12.8. Europe Contract Research Organization Services (CROs) Market Forecast, by Type 12.8.1. Early Phase Development Services 12.8.1.1. Discovery Studies 12.8.1.2. Chemistry, Manufacturing & Control 12.8.1.3. Preclinical Services 12.8.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 12.8.3. Toxicology Testing 12.8.4. Clinic Research Services 12.8.4.1. Phase I 12.8.4.2. Phase II 12.8.4.3. Phase III 12.8.4.4. Phase IV 12.8.5. Laboratory Services 12.8.5.1. Bioanalytical Testing 12.8.5.2. Analytical Testing 12.8.6. Physical Characterization 12.8.7. Stability Testing 12.8.8. Batch Release Testing 12.8.9. Raw Material Testing 12.8.10. Other Analytical Testing 12.8.11. Consulting Services 12.8.12. Other 12.9. Europe Contract Research Organization Services (CROs) Market Value Share Analysis, by Country 12.10. Europe Contract Research Organization Services (CROs) Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Contract Research Organization Services (CROs) Market Analysis, by Country 12.12. Germany Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 12.12.1. Oncology 12.12.2. Infectious Diseases 12.12.3. Central Nervous System (CNS) Disorders 12.12.4. Immunological Disorders 12.12.5. Cardiovascular Diseases 12.12.6. Respiratory Disorders 12.12.7. Diabetes 12.12.8. Other 12.13. Germany Contract Research Organization Services (CROs) Market Forecast, by End-user 12.13.1. Pharmaceutical & Biopharmaceutical Companies 12.13.2. Medical Device Companies 12.13.3. Academic Institutes 12.14. Germany Contract Research Organization Services (CROs) Market Forecast, by Type 12.14.1. Early Phase Development Services 12.14.1.1. Discovery Studies 12.14.1.2. Chemistry, Manufacturing & Control 12.14.1.3. Preclinical Services 12.14.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 12.14.3. Toxicology Testing 12.14.4. Clinic Research Services 12.14.4.1. Phase I 12.14.4.2. Phase II 12.14.4.3. Phase III 12.14.4.4. Phase IV 12.14.5. Laboratory Services 12.14.5.1. Bioanalytical Testing 12.14.5.2. Analytical Testing 12.14.6. Physical Characterization 12.14.7. Stability Testing 12.14.8. Batch Release Testing 12.14.9. Raw Material Testing 12.14.10. Other Analytical Testing 12.14.11. Consulting Services 12.14.12. Other 12.15. U.K. Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 12.15.1. Oncology 12.15.2. Infectious Diseases 12.15.3. Central Nervous System (CNS) Disorders 12.15.4. Immunological Disorders 12.15.5. Cardiovascular Diseases 12.15.6. Respiratory Disorders 12.15.7. Diabetes 12.15.8. Other 12.16. U.K. Contract Research Organization Services (CROs) Market Forecast, by End-user 12.16.1. Pharmaceutical & Biopharmaceutical Companies 12.16.2. Medical Device Companies 12.16.3. Academic Institutes 12.17. U.K. Contract Research Organization Services (CROs) Market Forecast, by Type 12.17.1. Early Phase Development Services 12.17.1.1. Discovery Studies 12.17.1.2. Chemistry, Manufacturing & Control 12.17.1.3. Preclinical Services 12.17.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 12.17.3. Toxicology Testing 12.17.4. Clinic Research Services 12.17.4.1. Phase I 12.17.4.2. Phase II 12.17.4.3. Phase III 12.17.4.4. Phase IV 12.17.5. Laboratory Services 12.17.5.1. Bioanalytical Testing 12.17.5.2. Analytical Testing 12.17.6. Physical Characterization 12.17.7. Stability Testing 12.17.8. Batch Release Testing 12.17.9. Raw Material Testing 12.17.10. Other Analytical Testing 12.17.11. Consulting Services 12.17.12. Other 12.18. France Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 12.18.1. Oncology 12.18.2. Infectious Diseases 12.18.3. Central Nervous System (CNS) Disorders 12.18.4. Immunological Disorders 12.18.5. Cardiovascular Diseases 12.18.6. Respiratory Disorders 12.18.7. Diabetes 12.18.8. Other 12.19. France Contract Research Organization Services (CROs) Market Forecast, by End-user 12.19.1. Pharmaceutical & Biopharmaceutical Companies 12.19.2. Medical Device Companies 12.19.3. Academic Institutes 12.20. France Contract Research Organization Services (CROs) Market Forecast, by Type 12.20.1. Early Phase Development Services 12.20.1.1. Discovery Studies 12.20.1.2. Chemistry, Manufacturing & Control 12.20.1.3. Preclinical Services 12.20.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 12.20.3. Toxicology Testing 12.20.4. Clinic Research Services 12.20.4.1. Phase I 12.20.4.2. Phase II 12.20.4.3. Phase III 12.20.4.4. Phase IV 12.20.5. Laboratory Services 12.20.5.1. Bioanalytical Testing 12.20.5.2. Analytical Testing 12.20.6. Physical Characterization 12.20.7. Stability Testing 12.20.8. Batch Release Testing 12.20.9. Raw Material Testing 12.20.10. Other Analytical Testing 12.20.11. Consulting Services 12.20.12. Other 12.21. Italy Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 12.21.1. Oncology 12.21.2. Infectious Diseases 12.21.3. Central Nervous System (CNS) Disorders 12.21.4. Immunological Disorders 12.21.5. Cardiovascular Diseases 12.21.6. Respiratory Disorders 12.21.7. Diabetes 12.21.8. Other 12.22. Italy Contract Research Organization Services (CROs) Market Forecast, by End-user 12.22.1. Pharmaceutical & Biopharmaceutical Companies 12.22.2. Medical Device Companies 12.22.3. Academic Institutes 12.23. Italy Contract Research Organization Services (CROs) Market Forecast, by Type 12.23.1. Early Phase Development Services 12.23.1.1. Discovery Studies 12.23.1.2. Chemistry, Manufacturing & Control 12.23.1.3. Preclinical Services 12.23.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 12.23.3. Toxicology Testing 12.23.4. Clinic Research Services 12.23.4.1. Phase I 12.23.4.2. Phase II 12.23.4.3. Phase III 12.23.4.4. Phase IV 12.23.5. Laboratory Services 12.23.5.1. Bioanalytical Testing 12.23.5.2. Analytical Testing 12.23.6. Physical Characterization 12.23.7. Stability Testing 12.23.8. Batch Release Testing 12.23.9. Raw Material Testing 12.23.10. Other Analytical Testing 12.23.11. Consulting Services 12.23.12. Other 12.24. Spain Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 12.24.1. Oncology 12.24.2. Infectious Diseases 12.24.3. Central Nervous System (CNS) Disorders 12.24.4. Immunological Disorders 12.24.5. Cardiovascular Diseases 12.24.6. Respiratory Disorders 12.24.7. Diabetes 12.24.8. Other 12.25. Spain Contract Research Organization Services (CROs) Market Forecast, by End-user 12.25.1. Pharmaceutical & Biopharmaceutical Companies 12.25.2. Medical Device Companies 12.25.3. Academic Institutes 12.26. Spain Contract Research Organization Services (CROs) Market Forecast, by Type 12.26.1. Early Phase Development Services 12.26.1.1. Discovery Studies 12.26.1.2. Chemistry, Manufacturing & Control 12.26.1.3. Preclinical Services 12.26.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 12.26.3. Toxicology Testing 12.26.4. Clinic Research Services 12.26.4.1. Phase I 12.26.4.2. Phase II 12.26.4.3. Phase III 12.26.4.4. Phase IV 12.26.5. Laboratory Services 12.26.5.1. Bioanalytical Testing 12.26.5.2. Analytical Testing 12.26.6. Physical Characterization 12.26.7. Stability Testing 12.26.8. Batch Release Testing 12.26.9. Raw Material Testing 12.26.10. Other Analytical Testing 12.26.11. Consulting Services 12.26.12. Other 12.27. Rest of Europe Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 12.27.1. Oncology 12.27.2. Infectious Diseases 12.27.3. Central Nervous System (CNS) Disorders 12.27.4. Immunological Disorders 12.27.5. Cardiovascular Diseases 12.27.6. Respiratory Disorders 12.27.7. Diabetes 12.27.8. Other 12.28. Rest of Europe Contract Research Organization Services (CROs) Market Forecast, by End-user 12.28.1. Pharmaceutical & Biopharmaceutical Companies 12.28.2. Medical Device Companies 12.28.3. Academic Institutes 12.29. Rest Of Europe Contract Research Organization Services (CROs) Market Forecast, by Type 12.29.1. Early Phase Development Services 12.29.1.1. Discovery Studies 12.29.1.2. Chemistry, Manufacturing & Control 12.29.1.3. Preclinical Services 12.29.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 12.29.3. Toxicology Testing 12.29.4. Clinic Research Services 12.29.4.1. Phase I 12.29.4.2. Phase II 12.29.4.3. Phase III 12.29.4.4. Phase IV 12.29.5. Laboratory Services 12.29.5.1. Bioanalytical Testing 12.29.5.2. Analytical Testing 12.29.6. Physical Characterization 12.29.7. Stability Testing 12.29.8. Batch Release Testing 12.29.9. Raw Material Testing 12.29.10. Other Analytical Testing 12.29.11. Consulting Services 12.29.12. Other 12.30. Europe Contract Research Organization Services (CROs) Market Attractiveness Analysis 12.30.1. By Therapeutic Area 12.30.2. By End-user 12.30.3. By Type 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Contract Research Organization Services (CROs) Market Analysis 13.1. Key Findings 13.2. Asia Pacific Contract Research Organization Services (CROs) Market Overview 13.3. Asia Pacific Contract Research Organization Services (CROs) Market Value Share Analysis, by Therapeutic Area 13.4. Asia Pacific Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 13.4.1. Oncology 13.4.2. Infectious Diseases 13.4.3. Central Nervous System (CNS) Disorders 13.4.4. Immunological Disorders 13.4.5. Cardiovascular Diseases 13.4.6. Respiratory Disorders 13.4.7. Diabetes 13.4.8. Other 13.5. Asia Pacific Contract Research Organization Services (CROs) Market Value Share Analysis, by End-user 13.6. Asia Pacific Contract Research Organization Services (CROs) Market Forecast, by End-user 13.6.1. Pharmaceutical & Biopharmaceutical Companies 13.6.2. Medical Device Companies 13.6.3. Academic Institutes 13.7. Asia Pacific Contract Research Organization Services (CROs) Market Value Share Analysis, by Type 13.8. Asia Pacific Contract Research Organization Services (CROs) Market Forecast, by Type 13.8.1. Early Phase Development Services 13.8.1.1. Discovery Studies 13.8.1.2. Chemistry, Manufacturing & Control 13.8.1.3. Preclinical Services 13.8.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 13.8.3. Toxicology Testing 13.8.4. Clinic Research Services 13.8.4.1. Phase I 13.8.4.2. Phase II 13.8.4.3. Phase III 13.8.4.4. Phase IV 13.8.5. Laboratory Services 13.8.5.1. Bioanalytical Testing 13.8.5.2. Analytical Testing 13.8.6. Physical Characterization 13.8.7. Stability Testing 13.8.8. Batch Release Testing 13.8.9. Raw Material Testing 13.8.10. Other Analytical Testing 13.8.11. Consulting Services 13.8.12. Other 13.9. Asia Pacific Contract Research Organization Services (CROs) Market Value Share Analysis, by Country 13.10. Asia Pacific Contract Research Organization Services (CROs) Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Contract Research Organization Services (CROs) Market Analysis, by Country 13.12. China Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 13.12.1. Oncology 13.12.2. Infectious Diseases 13.12.3. Central Nervous System (CNS) Disorders 13.12.4. Immunological Disorders 13.12.5. Cardiovascular Diseases 13.12.6. Respiratory Disorders 13.12.7. Diabetes 13.12.8. Other 13.13. China Contract Research Organization Services (CROs) Market Forecast, by End-user 13.13.1. Pharmaceutical & Biopharmaceutical Companies 13.13.2. Medical Device Companies 13.13.3. Academic Institutes 13.14. China Contract Research Organization Services (CROs) Market Forecast, by Type 13.14.1. Early Phase Development Services 13.14.1.1. Discovery Studies 13.14.1.2. Chemistry, Manufacturing & Control 13.14.1.3. Preclinical Services 13.14.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 13.14.3. Toxicology Testing 13.14.4. Clinic Research Services 13.14.4.1. Phase I 13.14.4.2. Phase II 13.14.4.3. Phase III 13.14.4.4. Phase IV 13.14.5. Laboratory Services 13.14.5.1. Bioanalytical Testing 13.14.5.2. Analytical Testing 13.14.6. Physical Characterization 13.14.7. Stability Testing 13.14.8. Batch Release Testing 13.14.9. Raw Material Testing 13.14.10. Other Analytical Testing 13.14.11. Consulting Services 13.14.12. Other 13.15. India Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 13.15.1. Oncology 13.15.2. Infectious Diseases 13.15.3. Central Nervous System (CNS) Disorders 13.15.4. Immunological Disorders 13.15.5. Cardiovascular Diseases 13.15.6. Respiratory Disorders 13.15.7. Diabetes 13.15.8. Other 13.16. India Contract Research Organization Services (CROs) Market Forecast, by End-user 13.16.1. Pharmaceutical & Biopharmaceutical Companies 13.16.2. Medical Device Companies 13.16.3. Academic Institutes 13.17. India Contract Research Organization Services (CROs) Market Forecast, by Type 13.17.1. Early Phase Development Services 13.17.1.1. Discovery Studies 13.17.1.2. Chemistry, Manufacturing & Control 13.17.1.3. Preclinical Services 13.17.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 13.17.3. Toxicology Testing 13.17.4. Clinic Research Services 13.17.4.1. Phase I 13.17.4.2. Phase II 13.17.4.3. Phase III 13.17.4.4. Phase IV 13.17.5. Laboratory Services 13.17.5.1. Bioanalytical Testing 13.17.5.2. Analytical Testing 13.17.6. Physical Characterization 13.17.7. Stability Testing 13.17.8. Batch Release Testing 13.17.9. Raw Material Testing 13.17.10. Other Analytical Testing 13.17.11. Consulting Services 13.17.12. Other 13.18. Japan Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 13.18.1. Oncology 13.18.2. Infectious Diseases 13.18.3. Central Nervous System (CNS) Disorders 13.18.4. Immunological Disorders 13.18.5. Cardiovascular Diseases 13.18.6. Respiratory Disorders 13.18.7. Diabetes 13.18.8. Other 13.19. Japan Contract Research Organization Services (CROs) Market Forecast, by End-user 13.19.1. Pharmaceutical & Biopharmaceutical Companies 13.19.2. Medical Device Companies 13.19.3. Academic Institutes 13.20. Japan Contract Research Organization Services (CROs) Market Forecast, by Type 13.20.1. Early Phase Development Services 13.20.1.1. Discovery Studies 13.20.1.2. Chemistry, Manufacturing & Control 13.20.1.3. Preclinical Services 13.20.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 13.20.3. Toxicology Testing 13.20.4. Clinic Research Services 13.20.4.1. Phase I 13.20.4.2. Phase II 13.20.4.3. Phase III 13.20.4.4. Phase IV 13.20.5. Laboratory Services 13.20.5.1. Bioanalytical Testing 13.20.5.2. Analytical Testing 13.20.6. Physical Characterization 13.20.7. Stability Testing 13.20.8. Batch Release Testing 13.20.9. Raw Material Testing 13.20.10. Other Analytical Testing 13.20.11. Consulting Services 13.20.12. Other 13.21. ASEAN Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 13.21.1. Oncology 13.21.2. Infectious Diseases 13.21.3. Central Nervous System (CNS) Disorders 13.21.4. Immunological Disorders 13.21.5. Cardiovascular Diseases 13.21.6. Respiratory Disorders 13.21.7. Diabetes 13.21.8. Other 13.22. ASEAN Contract Research Organization Services (CROs) Market Forecast, by End-user 13.22.1. Pharmaceutical & Biopharmaceutical Companies 13.22.2. Medical Device Companies 13.22.3. Academic Institutes 13.23. ASEAN Contract Research Organization Services (CROs) Market Forecast, by Type 13.23.1. Early Phase Development Services 13.23.1.1. Discovery Studies 13.23.1.2. Chemistry, Manufacturing & Control 13.23.1.3. Preclinical Services 13.23.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 13.23.3. Toxicology Testing 13.23.4. Clinic Research Services 13.23.4.1. Phase I 13.23.4.2. Phase II 13.23.4.3. Phase III 13.23.4.4. Phase IV 13.23.5. Laboratory Services 13.23.5.1. Bioanalytical Testing 13.23.5.2. Analytical Testing 13.23.6. Physical Characterization 13.23.7. Stability Testing 13.23.8. Batch Release Testing 13.23.9. Raw Material Testing 13.23.10. Other Analytical Testing 13.23.11. Consulting Services 13.23.12. Other 13.24. Rest of Asia Pacific Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 13.24.1. Oncology 13.24.2. Infectious Diseases 13.24.3. Central Nervous System (CNS) Disorders 13.24.4. Immunological Disorders 13.24.5. Cardiovascular Diseases 13.24.6. Respiratory Disorders 13.24.7. Diabetes 13.24.8. Other 13.25. Rest of Asia Pacific Contract Research Organization Services (CROs) Market Forecast, by End-user 13.25.1. Pharmaceutical & Biopharmaceutical Companies 13.25.2. Medical Device Companies 13.25.3. Academic Institutes 13.26. Rest of Asia Pacific Contract Research Organization Services (CROs) Market Forecast, by Type 13.26.1. Early Phase Development Services 13.26.1.1. Discovery Studies 13.26.1.2. Chemistry, Manufacturing & Control 13.26.1.3. Preclinical Services 13.26.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 13.26.3. Toxicology Testing 13.26.4. Clinic Research Services 13.26.4.1. Phase I 13.26.4.2. Phase II 13.26.4.3. Phase III 13.26.4.4. Phase IV 13.26.5. Laboratory Services 13.26.5.1. Bioanalytical Testing 13.26.5.2. Analytical Testing 13.26.6. Physical Characterization 13.26.7. Stability Testing 13.26.8. Batch Release Testing 13.26.9. Raw Material Testing 13.26.10. Other Analytical Testing 13.26.11. Consulting Services 13.26.12. Other 13.27. Asia Pacific Contract Research Organization Services (CROs) Market Attractiveness Analysis 13.27.1. By Therapeutic Area 13.27.2. By End-user 13.27.3. By Type 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Contract Research Organization Services (CROs) Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Contract Research Organization Services (CROs) Market Overview 14.3. Middle East & Africa Contract Research Organization Services (CROs) Market Value Share Analysis, by Therapeutic Area 14.4. Middle East & Africa Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 14.4.1. Oncology 14.4.2. Infectious Diseases 14.4.3. Central Nervous System (CNS) Disorders 14.4.4. Immunological Disorders 14.4.5. Cardiovascular Diseases 14.4.6. Respiratory Disorders 14.4.7. Diabetes 14.4.8. Other 14.5. Middle East & Africa Contract Research Organization Services (CROs) Market Value Share Analysis, by End-user 14.6. Middle East & Africa Contract Research Organization Services (CROs) Market Forecast, by End-user 14.6.1. Pharmaceutical & Biopharmaceutical Companies 14.6.2. Medical Device Companies 14.6.3. Academic Institutes 14.7. Middle East & Africa Contract Research Organization Services (CROs) Market Value Share Analysis, by Type 14.8. Middle East & Africa Contract Research Organization Services (CROs) Market Forecast, by Type 14.8.1. Early Phase Development Services 14.8.1.1. Discovery Studies 14.8.1.2. Chemistry, Manufacturing & Control 14.8.1.3. Preclinical Services 14.8.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 14.8.3. Toxicology Testing 14.8.4. Clinic Research Services 14.8.4.1. Phase I 14.8.4.2. Phase II 14.8.4.3. Phase III 14.8.4.4. Phase IV 14.8.5. Laboratory Services 14.8.5.1. Bioanalytical Testing 14.8.5.2. Analytical Testing 14.8.6. Physical Characterization 14.8.7. Stability Testing 14.8.8. Batch Release Testing 14.8.9. Raw Material Testing 14.8.10. Other Analytical Testing 14.8.11. Consulting Services 14.8.12. Other 14.9. Middle East & Africa Contract Research Organization Services (CROs) Market Value Share Analysis, by Country 14.10. Middle East & Africa Contract Research Organization Services (CROs) Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Contract Research Organization Services (CROs) Market Analysis, by Country 14.12. GCC Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 14.12.1. Oncology 14.12.2. Infectious Diseases 14.12.3. Central Nervous System (CNS) Disorders 14.12.4. Immunological Disorders 14.12.5. Cardiovascular Diseases 14.12.6. Respiratory Disorders 14.12.7. Diabetes 14.12.8. Other 14.13. GCC Contract Research Organization Services (CROs) Market Forecast, by End-user 14.13.1. Pharmaceutical & Biopharmaceutical Companies 14.13.2. Medical Device Companies 14.13.3. Academic Institutes 14.14. GCC Contract Research Organization Services (CROs) Market Forecast, by Type 14.14.1. Early Phase Development Services 14.14.1.1. Discovery Studies 14.14.1.2. Chemistry, Manufacturing & Control 14.14.1.3. Preclinical Services 14.14.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 14.14.3. Toxicology Testing 14.14.4. Clinic Research Services 14.14.4.1. Phase I 14.14.4.2. Phase II 14.14.4.3. Phase III 14.14.4.4. Phase IV 14.14.5. Laboratory Services 14.14.5.1. Bioanalytical Testing 14.14.5.2. Analytical Testing 14.14.6. Physical Characterization 14.14.7. Stability Testing 14.14.8. Batch Release Testing 14.14.9. Raw Material Testing 14.14.10. Other Analytical Testing 14.14.11. Consulting Services 14.14.12. Other 14.15. South Africa Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 14.15.1. Oncology 14.15.2. Infectious Diseases 14.15.3. Central Nervous System (CNS) Disorders 14.15.4. Immunological Disorders 14.15.5. Cardiovascular Diseases 14.15.6. Respiratory Disorders 14.15.7. Diabetes 14.15.8. Other 14.16. South Africa Contract Research Organization Services (CROs) Market Forecast, by End-user 14.16.1. Pharmaceutical & Biopharmaceutical Companies 14.16.2. Medical Device Companies 14.16.3. Academic Institutes 14.17. South Africa Contract Research Organization Services (CROs) Market Forecast, by Type 14.17.1. Early Phase Development Services 14.17.1.1. Discovery Studies 14.17.1.2. Chemistry, Manufacturing & Control 14.17.1.3. Preclinical Services 14.17.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 14.17.3. Toxicology Testing 14.17.4. Clinic Research Services 14.17.4.1. Phase I 14.17.4.2. Phase II 14.17.4.3. Phase III 14.17.4.4. Phase IV 14.17.5. Laboratory Services 14.17.5.1. Bioanalytical Testing 14.17.5.2. Analytical Testing 14.17.6. Physical Characterization 14.17.7. Stability Testing 14.17.8. Batch Release Testing 14.17.9. Raw Material Testing 14.17.10. Other Analytical Testing 14.17.11. Consulting Services 14.17.12. Other 14.18. Rest of Middle East & Africa Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 14.18.1. Oncology 14.18.2. Infectious Diseases 14.18.3. Central Nervous System (CNS) Disorders 14.18.4. Immunological Disorders 14.18.5. Cardiovascular Diseases 14.18.6. Respiratory Disorders 14.18.7. Diabetes 14.18.8. Other 14.19. Rest of Middle East & Africa Contract Research Organization Services (CROs) Market Forecast, by End-user 14.19.1. Contract Research Organizations 14.19.2. Diagnostic Laboratories 14.19.3. Hospitals 14.19.4. Academic Institute 14.20. Rest of Middle East & Africa Contract Research Organization Services (CROs) Market Forecast, by Type 14.20.1. Early Phase Development Services 14.20.1.1. Discovery Studies 14.20.1.2. Chemistry, Manufacturing & Control 14.20.1.3. Preclinical Services 14.20.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 14.20.3. Toxicology Testing 14.20.4. Clinic Research Services 14.20.4.1. Phase I 14.20.4.2. Phase II 14.20.4.3. Phase III 14.20.4.4. Phase IV 14.20.5. Laboratory Services 14.20.5.1. Bioanalytical Testing 14.20.5.2. Analytical Testing 14.20.6. Physical Characterization 14.20.7. Stability Testing 14.20.8. Batch Release Testing 14.20.9. Raw Material Testing 14.20.10. Other Analytical Testing 14.20.11. Consulting Services 14.20.12. Other 14.21. Middle East & Africa Contract Research Organization Services (CROs) Market Attractiveness Analysis 14.21.1. By Therapeutic Area 14.21.2. By End-user 14.21.3. By Type 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Contract Research Organization Services (CROs) Market Analysis 15.1. Key Findings 15.2. South America Contract Research Organization Services (CROs) Market Overview 15.3. South America Contract Research Organization Services (CROs) Market Value Share Analysis, by Therapeutic Area 15.4. South America Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 15.4.1. Oncology 15.4.2. Infectious Diseases 15.4.3. Central Nervous System (CNS) Disorders 15.4.4. Immunological Disorders 15.4.5. Cardiovascular Diseases 15.4.6. Respiratory Disorders 15.4.7. Diabetes 15.4.8. Other 15.5. South America Contract Research Organization Services (CROs) Market Value Share Analysis, by End-user 15.6. South America Contract Research Organization Services (CROs) Market Forecast, by End-user 15.6.1. Pharmaceutical & Biopharmaceutical Companies 15.6.2. Medical Device Companies 15.6.3. Academic Institutes 15.7. South America Contract Research Organization Services (CROs) Market Value Share Analysis, by Type 15.8. South America Contract Research Organization Services (CROs) Market Forecast, by Type 15.8.1. Early Phase Development Services 15.8.1.1. Discovery Studies 15.8.1.2. Chemistry, Manufacturing & Control 15.8.1.3. Preclinical Services 15.8.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 15.8.3. Toxicology Testing 15.8.4. Clinic Research Services 15.8.4.1. Phase I 15.8.4.2. Phase II 15.8.4.3. Phase III 15.8.4.4. Phase IV 15.8.5. Laboratory Services 15.8.5.1. Bioanalytical Testing 15.8.5.2. Analytical Testing 15.8.6. Physical Characterization 15.8.7. Stability Testing 15.8.8. Batch Release Testing 15.8.9. Raw Material Testing 15.8.10. Other Analytical Testing 15.8.11. Consulting Services 15.8.12. Other 15.9. South America Contract Research Organization Services (CROs) Market Value Share Analysis, by Country 15.10. South America Contract Research Organization Services (CROs) Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Contract Research Organization Services (CROs) Market Analysis, by Country 15.12. Brazil Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 15.12.1. Oncology 15.12.2. Infectious Diseases 15.12.3. Central Nervous System (CNS) Disorders 15.12.4. Immunological Disorders 15.12.5. Cardiovascular Diseases 15.12.6. Respiratory Disorders 15.12.7. Diabetes 15.12.8. Other 15.13. Brazil Contract Research Organization Services (CROs) Market Forecast, by End-user 15.13.1. Pharmaceutical & Biopharmaceutical Companies 15.13.2. Medical Device Companies 15.13.3. Academic Institutes 15.14. Brazil Contract Research Organization Services (CROs) Market Forecast, by Type 15.14.1. Early Phase Development Services 15.14.1.1. Discovery Studies 15.14.1.2. Chemistry, Manufacturing & Control 15.14.1.3. Preclinical Services 15.14.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 15.14.3. Toxicology Testing 15.14.4. Clinic Research Services 15.14.4.1. Phase I 15.14.4.2. Phase II 15.14.4.3. Phase III 15.14.4.4. Phase IV 15.14.5. Laboratory Services 15.14.5.1. Bioanalytical Testing 15.14.5.2. Analytical Testing 15.14.6. Physical Characterization 15.14.7. Stability Testing 15.14.8. Batch Release Testing 15.14.9. Raw Material Testing 15.14.10. Other Analytical Testing 15.14.11. Consulting Services 15.14.12. Other 15.15. Mexico Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 15.15.1. Oncology 15.15.2. Infectious Diseases 15.15.3. Central Nervous System (CNS) Disorders 15.15.4. Immunological Disorders 15.15.5. Cardiovascular Diseases 15.15.6. Respiratory Disorders 15.15.7. Diabetes 15.15.8. Other 15.16. Mexico Contract Research Organization Services (CROs) Market Forecast, by End-user 15.16.1. Pharmaceutical & Biopharmaceutical Companies 15.16.2. Medical Device Companies 15.16.3. Academic Institutes 15.17. Mexico Contract Research Organization Services (CROs) Market Forecast, by Type 15.17.1. Early Phase Development Services 15.17.1.1. Discovery Studies 15.17.1.2. Chemistry, Manufacturing & Control 15.17.1.3. Preclinical Services 15.17.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 15.17.3. Toxicology Testing 15.17.4. Clinic Research Services 15.17.4.1. Phase I 15.17.4.2. Phase II 15.17.4.3. Phase III 15.17.4.4. Phase IV 15.17.5. Laboratory Services 15.17.5.1. Bioanalytical Testing 15.17.5.2. Analytical Testing 15.17.6. Physical Characterization 15.17.7. Stability Testing 15.17.8. Batch Release Testing 15.17.9. Raw Material Testing 15.17.10. Other Analytical Testing 15.17.11. Consulting Services 15.17.12. Other 15.18. Rest of South America Contract Research Organization Services (CROs) Market Forecast, by Therapeutic Area 15.18.1. Oncology 15.18.2. Infectious Diseases 15.18.3. Central Nervous System (CNS) Disorders 15.18.4. Immunological Disorders 15.18.5. Cardiovascular Diseases 15.18.6. Respiratory Disorders 15.18.7. Diabetes 15.18.8. Other 15.19. Rest of South America Contract Research Organization Services (CROs) Market Forecast, by End-user 15.19.1. Pharmaceutical & Biopharmaceutical Companies 15.19.2. Medical Device Companies 15.19.3. Academic Institutes 15.20. Rest of South America Contract Research Organization Services (CROs) Market Forecast, by Type 15.20.1. Early Phase Development Services 15.20.1.1. Discovery Studies 15.20.1.2. Chemistry, Manufacturing & Control 15.20.1.3. Preclinical Services 15.20.2. Pharmacokinetics/Pharmacodynamics (PK/PD) 15.20.3. Toxicology Testing 15.20.4. Clinic Research Services 15.20.4.1. Phase I 15.20.4.2. Phase II 15.20.4.3. Phase III 15.20.4.4. Phase IV 15.20.5. Laboratory Services 15.20.5.1. Bioanalytical Testing 15.20.5.2. Analytical Testing 15.20.6. Physical Characterization 15.20.7. Stability Testing 15.20.8. Batch Release Testing 15.20.9. Raw Material Testing 15.20.10. Other Analytical Testing 15.20.11. Consulting Services 15.20.12. Other 15.21. South America Contract Research Organization Services (CROs) Market Attractiveness Analysis 15.21.1. By Therapeutic Area 15.21.2. By End-user 15.21.3. By Type 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.4.1. MPI Research 16.4.1.1. Company Overview 16.4.1.2. Financial Overview 16.4.1.3. Product Portfolio 16.4.1.4. Business Strategy 16.4.1.5. Recent Developments 16.4.1.6. Manufacturing Footprint 16.4.2. Quintiles Transnational Holdings Inc. 16.4.3. Envigo 16.4.4. SGS 16.4.5. MeDPAce Holdings 16.4.6. Charles River 16.4.7. WuXi Pharmatech 16.4.8. INC Research Holdings, Inc. 16.4.9. Syneos Health 16.4.10. ICON PLC 16.4.11. PPD 16.4.12. PRA Health Sciences 16.4.13. PAREXEL 16.4.14. LabCorp 16.4.15. IQVIA 17. Primary Key Insights

About This Report

Report ID6679
Published Date
Contact Us
Call Now